Stericycle's CEO Discusses Q4 2011 Results - Earnings Call Transcript

Stericycle (SRCL)

Q4 2011 Earnings Call

February 02, 2012 5:00 pm ET

Executives

Laura A. Murphy - Vice President of Corporate Finance

Frank J. M. ten Brink - Chief Financial Officer, Chief Accounting officer and Executive Vice President of Finance

Richard Kogler - Chief Operating Officer and Executive Vice President

Mark C. Miller - Chairman, Chief Executive Officer and President

Analysts

Ryan Daniels - William Blair & Company L.L.C., Research Division

Scott J. Levine - JP Morgan Chase & Co, Research Division

Jonathan Demchick - Morgan Stanley, Research Division

Albert Leo Kaschalk - Wedbush Securities Inc., Research Division

Scott A. Schneeberger - Oppenheimer & Co. Inc., Research Division

David J. Manthey - Robert W. Baird & Co. Incorporated, Research Division

Richard C. Close - Avondale Partners, LLC, Research Division

Shlomo Rosenbaum - Stifel, Nicolaus & Co., Inc., Research Division

Gregory Halter

Presentation

Operator

Good afternoon. My name is Jessica, and I will be your conference operator today. At this time, I'd to welcome everyone to the fourth quarter 2011 earnings release conference call. [Operator Instructions] Thank you. Laura Murphy, Vice President, Corporate Finance, you may begin your conference.

Laura A. Murphy

Welcome to Stericycle's Quarterly Conference Call. Joining me on today's call will be Frank ten Brink, CFO; Rich Kogler, COO; and Mark Miller, Chairman and CEO.

I will now read the Safe Harbor statement. Statements by Stericycle in this conference call that are not strictly historical are forward looking. Forward-looking statements involve known and unknown risks and should be viewed with caution. Factors described in the company's Form 10-K, 10-Qs, as well as its other filings with the SEC, could affect the company's actual results and could cause the company's actual results to differ materially from expected results. The company makes no commitment to disclose any revisions to forward-looking statements or any facts, events or circumstances after this date that may bear upon forward-looking statements.

If you liked this article you might like

The Value of an Overvalued Market: Cramer's 'Mad Money' Recap (Thursday 8/10/17)

Wide Moat, Bargain Price

Analysts' Actions -- Akamai, Estee Lauder, Hess, Ferrari and More

Stericycle Setting Up for a Breakout

Stericycle Started With 'Overweight' Rating at Barclays